Jing Tong

Jing Tong

Bristol-Myers Squibb Co. - New York / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4398156
-
person_outline Jing Tong's MOST POPULAR ARTICLES
1-) Poly (2‐oxazoline) s as Polymer TherapeuticsR Luxenhofer, Y Han, A Schulz, J Tong, Z He, AV Kabanov, R JordanMacromolecular rapid communications 33 (19), 1613-1631, 20125242012
2-) Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly (2-oxazoline) s nanoformulationJ Tong, MC Zimmerman, S Li, X Yi, R Luxenhofer, R Jordan, AV KabanovBiomaterials 32 (14), 3654-3665, 20111192011
3-) Protein modification with amphiphilic block copoly (2-oxazoline) s as a new platform for enhanced cellular deliveryJ Tong, R Luxenhofer, X Yi, R Jordan, AV KabanovMolecular pharmaceutics 7 (4), 984-992, 2010932010
4-) Conjugates of superoxide dismutase 1 with amphiphilic poly (2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and …J Tong, X Yi, R Luxenhofer, WA Banks, R Jordan, MC Zimmerman, ...Molecular pharmaceutics 10 (1), 360-377, 2013902013
5-) Poly (2‐oxazoline) block copolymer based formulations of taxanes: effect of copolymer and drug structure, concentration, and environmental factorsY Seo, A Schulz, Y Han, Z He, H Bludau, X Wan, J Tong, TK Bronich, ...Polymers for Advanced Technologies 26 (7), 837-850, 2015752015